Markers of inflammation in patients with symptomatic and asymptomatic carotid artery stenosis: A case-control study

Vascular and Endovascular Surgery

Volumn 42, Issue 2, 2008, Pages 122-127

  Debing, Erik ^a   Peeters, Els ^a   Demanet, Christian ^a   De Waele, Marc ^a   Van Den Brande, Pierre ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Atherosclerosis; Carotid endarterectomy; Case control; Inflammatory markers

Indexed keywords

C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; CASE-CONTROL STUDIES; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 42249090371     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574407307406     Document Type: Article

References (26)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 ; 340: 115-126.
2. Koenig W., Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol. 2007 ; 27: 15-26.
3. Danesh J., Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004 ; 350: 1387-1397.
4. Boekholdt SM, Hack CE, Sandhu MS, et al. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003. Atherosclerosis. 2006 ; 187: 415-422.
5. Magliano DJ, Liew D., Ashton EL, Sundararajan V., McNeil JJ Novel biomedical risk markers for cardiovascular disease. J Cardiovasc Dis. 2003 ; 10: 41-55.
6. Kaperonis EA, Liapis CD, Kakisis JD, Dimitroulis D., Papavassiliou VG Inflammation and atherosclerosis. Eur J Vasc Endovasc Surg. 2006 ; 31: 386-393.
7. Morrone G., Ciliberto G., Oliviero S., et al. Recombinant interleukin-6 regulates the transcriptional activation of a set of human acute phase genes. J Biol Chem. 1988 ; 263: 12554-12558.
8. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003 ; 170: 191-203.
9. Schillinger M., Exner M., Mlekusch W., et al. Inflammation and carotid artery-risk for atherosclerosis study (ICARAS). Circulation. 2005 ; 111: 2203-2209.
10. Kondo K., Kitagawa K., Nagai Y., Yamagami H., Hashimoto H., Hougaku H. Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis. 2004 ; 179: 155-160.
11. Baker JD, Rutherford RB, Bernstein EF, Courbier R., Ernst CB, Kempczinski RF Suggested standards for reports dealing with cerebrovascular disease. J Vasc Surg. 1988 ; 8: 721-729.
12. Mocco J., Choudri TF, Mack WJ, et al. Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery. 2001 ; 48: 718-722.
13. Rerkasem K., Shearman CP, Williams JA, et al. C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Endovasc Surg. 2002 ; 23: 505-509.
14. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003 ; 170: 191-203.
15. Jager A., van Hinsbergh VW, Kostense PJ, et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the HOORN study. Diabetes. 2000 ; 48: 183-189.
16. Clearfield MB C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc. 2005 ; 9: 409-416.
17. Lemieux I., Pascot A., Prud'homme D., et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001 ; 21: 391-397.
18. Pradhan AD, Manson JE, Rifai N., Buring JE, Ridker PM C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001 ; 286: 327-334.
19. Ridker PM, Rifai N., Pfeffer MA, Sacks F., Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1999 ; 100: 230-235.
20. Larsson PT, Hallerstam S., Rosfors S., Wallen NH Circulating markers of inflammation are related to carotid artery atherosclerosis. Int Angiol. 2005 ; 24: 43-51.
21. De Caterina R., Basta G., Lazzerini G., et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol. 1997 ; 17: 2646-2654.
22. Rohde LE, Lee RT, Rivero J., et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 1998 ; 18: 1765-1770.
23. Kondo K., Kitagawa K., Nagai Y., et al. Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis. 2005 ; 179: 155-160.
24. Romano M., Mezzetti A., Marulli C., et al. Fluvastatin reduces soluble P-selectin and ICAM-levels in hypercholesterolemic patients: role of nitric oxide. J Invest Med. 2000 ; 48: 183-189.
25. Glass CK, Witztum JL Atherosclerosis, the road ahead. Cell. 2001 ; 104: 503-516
26. Lusis AJ Atherosclerosis. Nature. 2000 ; 407: 233-241.